您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版)

• 临床医学 • 上一篇    下一篇

Graves病患者131I治疗后TRAb变化与早发甲减的相关性

王付颖1,刘晓萌2,董庆玉2,梁翠格2,杜文华2,王月丽2,李文侠2,高冠起2   

  1. 1. 泰山医学院研究生部, 山东 泰安 271016; 2. 临沂市人民医院内分泌科, 山东 临沂 276003
  • 收稿日期:2013-10-31 出版日期:2014-06-10 发布日期:2014-06-10
  • 通讯作者: 高冠起。E-mail:lygqgao@163.com
  • 基金资助:
    山东省自然科学基金(ZR2011HM067)

Dynamic changes of serum TRAb concentration after 131I treatment of Graves’ disease and its association with early hypothyroidism

WANG Fuying1, LIU Xiaomeng2, DONG Qingyu2, LIANG Cuige2, DU Wenhua2, WANG Yueli2, LI Wenxia2, GAO Guanqi2   

  1. 1. Graduate Department of Taishan Medical University, Taian 271016, Shandong, China;
    2. Department of Endocrinology, Linyi Peoples Hospital, Linyi 276003, Shandong, China
  • Received:2013-10-31 Online:2014-06-10 Published:2014-06-10

摘要: 目的  观察Graves病(GD)患者131I治疗后促甲状腺激素受体抗体(TRAb)动态变化,并分析其与早发甲减的相关性。方法  131I治疗的240例初诊GD患者,分为早发甲减组(n=134)和非早发甲减组(n=106),测定131I治疗前及治疗后3、6、12个月时TRAb浓度。结果  两组患者TRAb浓度在131I治疗后3个月升高,6个月时达到高峰,至12个月时降至治疗前水平;早发甲减组患者131I治疗后6个月TRAb高于非早发甲减组(F=13.967,P<0.01)。结论  GD 患者131I治疗后1年内TRAb呈现一过性升高,其与早发甲减密切相关,TRAb动态变化对早期判断GD 131I治疗预后具有重要的临床价值。

关键词: 促甲状腺激素受体抗体, Graves病, 早发甲减, 131碘

Abstract: Objective  To observe the change of serum thyrophin receptor antibody (TRAb) in patients with Graves’ disease (GD) after 131I radiotherapy, and to investigate its association with early hypothyroidism. Methods  A total of 240 patients with GD were divided into two groups: early hypothyroidism group (n=134), and non-early hypothyroidism group (n=106), according to the occurrence of early hypothyroidism after treatment. Serum concentration of TRAb was measured by radioreceptor assay before, 3, 6 and 12 months after 131I radiotherapy. Results  In both groups, serum TRAb titer increased at the 3rd month, reached the highest level at the 6th month, and returned to the baseline level at the 12th month. The TRAb titer of early hypothyroidism group was higher than that of non-early hypothyroidism group at the 6th month, and there was a significant difference between the two groups (F=13.967, P<0.01). Conclusion  The dynamic change of serum TRAb before and after 131I radiotherapy is closely related to the occurrence of early hypothyroidism, and plays an important role in the prognosis after 131I treatment of GD.

Key words: Graves&rsquo, disease, Thyrotropin receptors antibodies, Iodine radioisotopes, Hypothyroidism

中图分类号: 

  • R581.1
[1] 刘攀,何天祎,赵汝星,孙宇,陈丽. 百令胶囊对Graves病患者自身免疫的调理作用[J]. 山东大学学报(医学版), 2017, 55(9): 90-95.
[2] 刘静,陈福琴. 血清硒水平与Graves病复发的关系及机制探讨[J]. 山东大学学报(医学版), 2012, 50(7): 5-.
[3] 张王峰1,叶常青2,袁梦晖3,蒋仁晶1,徐文斌1,卢受强1,李惕1. 甲状腺功能亢进伴白细胞减少患者131I治疗前后白细胞观察[J]. 山东大学学报(医学版), 2010, 48(4): 162-164.
[4] . Graves病131治疗后1年内早发甲减影响因素分析[J]. 山东大学学报(医学版), 2009, 47(9): 5-6.
[5] 王宏伟 张莹 陈福琴. Graves病患者外周血FOXP3、GITR及CD25基因的表达[J]. 山东大学学报(医学版), 2009, 47(12): 1-5.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!